Vuity and Retinal tear - a phase IV clinical study of FDA data

Summary:

Retinal tear is reported as a side effect among people who take Vuity (pilocarpine hydrochloride), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Amlodipine, and have Presbyopia.

The phase IV clinical study analyzes which people have Retinal tear when taking Vuity. It is created by eHealthMe based on reports of 933 people who have side effects when taking Vuity from the FDA, and is updated regularly.

What is Vuity?

Vuity has active ingredients of pilocarpine hydrochloride. eHealthMe is studying from 934 Vuity users. Check the latest studies of Vuity.

What is Retinal tear?

Retinal tear is found to be associated with 326 drugs and 466 conditions by eHealthMe. Check the latest studies of Retinal tear.

On Jul, 21, 2026

933 people reported to have side effects when taking Vuity.
Among them, 26 people (2.79%) have Retinal tear.

Among these 26 people:

How long have people been on Vuity when they have Retinal tear? *

What is the gender of people who have Retinal tear when taking Vuity? *

female: 26.09 %
male: 73.91 %

What is the age of people who have Retinal tear when taking Vuity? *

What are other drugs people take besides Vuity? *

Lisinopril: 1 person, 3.85%
Cialis: 1 person, 3.85%
Amlodipine: 1 person, 3.85%

What are other side effects people have besides Retinal tear? *

Vitreous Floaters (spots before the eyes): 9 people, 34.62%
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue): 9 people, 34.62%
Vitreous Detachment (a condition of the eye in which the vitreous humour separates from the retina): 8 people, 30.77%
Photopsia (presence of perceived flashes of light): 7 people, 26.92%
Vision Blurred: 2 people, 7.69%
Retinal Degeneration (death of the cells of the retina): 2 people, 7.69%
Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 1 person, 3.85%
Quality Of Life Decreased: 1 person, 3.85%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 1 person, 3.85%
Headache (pain in head): 1 person, 3.85%

What are the existing conditions these people have? *

Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close): 16 people, 61.54%
Visual Impairment: 2 people, 7.69%
Visual Acuity Reduced (reduced clearness of vision): 1 person, 3.85%
Photosensitivity Reaction: 1 person, 3.85%
High Blood Pressure: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Vuity and have Retinal tear?

- Check whether Retinal tear is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vuity:

Vuity (934 reports)

Retinal tear treatments and more:

Retinal tear (2,985 reports)

Browse all side effects of Vuity:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal tear:

Retinal tear (326 drugs)

Browse all the conditions that are associated with Retinal tear:

Retinal tear (466 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pilocarpine hydrochloride (the active ingredients of Vuity) and Vuity (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.